Vimarsana
Biggest News Aggregation in the World

Clinical Studies Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Studies Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Studies Network Today - Breaking & Trending Today

ALJAZAM The Stream October 16, 2014 - Vimarsana News

ALJAZAM The Stream October 16, 2014

Cdc that will go within hours to any hospital that has an ebola case to help them provide effective care safely. Theres a lot of understandable concern about the cases in dallas. I have one slide, if we can show it, of the contacttracing activities there, and i think we have provided copies for the members. The two core activities in dallas are to ensure that there is effective Infection Control and to trace contacts. Here you see a time line in exactly what has happened in the indication of contacts. We have followed each of the contacts. When any become will, we immediately isolate them, so ...

BARDA awards up to $500 million in Project NextGen funding for vaccine clinical trials - Vimarsana News

BARDA awards up to $500 million in Project NextGen funding for vaccine clinical trials

BARDA awards up to $500 million in Project NextGen funding for vaccine clinical trials

Source: hhs.gov
Rho to Lead U.S. Clinical Trials for Next Generation of COVID-19 Vaccines ... - Vimarsana News

Rho to Lead U.S. Clinical Trials for Next Generation of COVID-19 Vaccines ...

Rho to Lead U.S. Clinical Trials for Next Generation of COVID-19 Vaccines ...

Allucent to expedite Covid-19 booster vaccines development - Vimarsana News

Allucent to expedite Covid-19 booster vaccines development

Allucent has received a contract from the BARDA to expedite clinical research and development of next-generation booster vaccines for Covid-19.

Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster Vaccines - Vimarsana News

Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster Vaccines

/PRNewswire/ -- Allucent, a global mid-sized clinical research organization (CRO), announced that it has been selected by the Biomedical Advanced Research and...